NCT04260243Not yet recruiting
Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease
Effects of Myofascial Release in Patients with Chronic Obstructive Pulmonary Disease: a Randomized Clinical Trial
Source: ClinicalTrials.gov · Last updated 12 Feb 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The main objective of this study is to assess the effects of a myofascial release protocol in patients with chronic obstructive pulmonary disease (COPD).
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 5 Feb 2020
- Start date
- 1 Mar 2026
- Primary completion date
- 31 Mar 2027
- Lead sponsor
- Cardenal Herrera University
- Diseases
- COPD
- NCT number
- NCT04260243
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 1 Mar 2026 to the primary completion date, 31 Mar 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Recent (6 months) spine or abdominal surgery;
- previous myofascial release treatment.
Other illness
- Allergic status of any kind;
- systemic diseases (rheumatic, infectious conditions, febrile state, vascular alterations, endocrine diseases including diabetes, metabolic, and neoplastic syndromes);
Other
- neuromuscular or neurological injuries;
Who the study is looking for
- COPD;
- Forced expiratory volume in the first second (FEV1) \< 80%;
- FEV1/Forced vital capacity (FVC) \< 70%;
- Maximal inspiratory pressure (MIP) \< 70%.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.